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Abstract
The biological activity of osteoblasts and osteoclasts is regulated not only by hormones but also by local growth factors, which are expressed in
neighbouring cells or included in bone matrix. Previously, we developed hydroxyapatite (HA) composed of rod-shaped particles using applied
hydrothermal methods (HHA), and it revealed mild biodegradability and potent osteoclast homing activity. Here, we compared serum proteins
adsorbed to HHA with those adsorbed to conventional HA composed of globular-shaped particles (CHA). The two ceramics adsorbed serum
albumin and c-globulin to similar extents, but affinity for c-globulin was much greater than that to serum albumin. The chemotactic activity for
macrophages of serum proteins adsorbed to HHA was significantly higher than that of serum proteins adsorbed to CHA. Quantitative proteomic
analysis of adsorbed serum proteins revealed preferential binding of vitamin D-binding protein (DBP) and complements C3 and C4B with HHA.
When implanted with the femur of 8-week-old rats, HHA contained significantly larger amount of DBP than CHA. The biological activity of DBP
was analysed and it was found that the chemotactic activity for macrophages was weak. However, DBP-macrophage activating factor, which is
generated by the digestion of sugar chains of DBP, stimulated osteoclastogenesis. These results confirm that the microstructure of hydroxy-
apatite largely affects the affinity for serum proteins, and suggest that DBP preferentially adsorbed to HA composed of rod-shaped particles
influences its potent osteoclast homing activity and local bone metabolism.
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Introduction
Bone metabolism is strictly regulated by the balance of osteogenic
activity of osteoblasts and bone resorbing activity of osteoclasts. The
biological activities of osteoblasts and osteoclasts are regulated not
only by hormones but also by local factors. The importance of hor-
monal regulation of bone metabolism is obvious considering symp-
toms of diseases like hypercalcaemia and osteopenia caused by
hyperparathyroidism and osteoporosis caused by oestrogen defi-
ciency in post-menopause [1–3]. In addition to hormonal regulation,
local regulation has also been found to be very important to bone
metabolism. Potent osteogenic factors, bone morphogenetic proteins
(BMPs), were initially isolated from bone matrix proteins.
Interestingly, osteoblasts in turn express one of the most impor-
tant osteoclastogenic factors, receptor activator of nuclear factor
kappa-B ligand (RANKL). When RANKL binds to its receptor RANK,
which is expressed in osteoclast progenitor cells, osteoclast progeni-
tor cells differentiate into osteoclasts [4]. In addition to the coupling
of bone formation to resorption described above, many types of
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interconnected cell biological regulation have been shown to contrib-
ute to regulate bone metabolism [5–9]. Hence, study of the local reg-
ulation of bone metabolism in regions implanted with a bone
substitute is very important.
Previously, we developed a unique calcium-deficient hydroxyapa-
tite (HA) composed of rod-shaped particles using applied hydrother-
mal methods [10]. We implanted a cylindrical block of HA composed
of rod-shaped particles prepared by applied hydrothermal methods
(HHA) and HA synthesized by conventional sintering (CHA) into rabbit
femurs and compared their biological behaviours. Surprisingly, HHA
exhibited biodegradability in contrast to CHA, which was almost un-
biodegradable during 24 weeks after implantation. It was striking that
bone volume/tissue volume (BV/TV) and number of osteoclasts/bone
perimeter (N.Oc/B.Pm) were significantly larger in the regions
implanted with HHA than those implanted with CHA [11]. These find-
ings were confirmed in a rat implantation model using spherical gran-
ules of HHA and CHA. In addition, stimulation of osteogenesis was
suggested to be associated with osteoclasts from the finding that cul-
ture supernatants of osteoclasts stimulated the differentiation of os-
teoblasts [12].
Considering these findings, potent osteoclast homing activity of
HHA might be associated with larger BV/TV in regions implanted with
HHA than those implanted with CHA. However, the mechanism of
potent osteoclast homing activity of HHA remains unclear. The biode-
gradable nature of HHA is thought to increase the local concentration
of calcium and/or phosphate, and it may affect local bone metabolism
through regulation of the biological activity of osteoblasts and osteo-
clasts as suggested previously [13–16]. Hence, high turnover of bone
metabolism in the region implanted with HHA, which we reported pre-
viously, might be associated with the biodegradation of HHA [17].
Surface roughness of implant materials has been reported to stimu-
late osteogenesis [18, 19], and a rod-shaped microstructure might
also be directly associated with osteogenesis or osteoclastogenesis in
the implanted region. Considering the importance of bone matrix pro-
teins included in the bone-to-bone metabolism by their release from
bone upon osteoclastic bone resorption, there is also a possibility that
proteins adsorbed to implanted porous bone substitutes affect local
bone metabolism. In this study, the mechanism of potent osteoclast
homing activity of HHA was analysed by characterizing its affinity for
serum proteins. The biological activity of serum protein preferentially
adsorbed to HHA was also analysed.
Materials and methods
Preparation of ceramics
Alpha-tricalcium phosphate (a-TCP) powder (Taihei Chemical Ind. Co.
Ltd., Osaka, Japan) was mixed and kneaded with 10% gelatine solution,
and dropped into a stirred oil bath heated at 80°C. The bath was then
chilled on ice and spherical a-TCP/gelatine granules were formed. The
granules were separated from the oil, rinsed and sintered at 1200°C for
10 min. to remove the gelatine and to maintain the crystal phase of a-
TCP. The formed a-TCP granules were set in an autoclave at 160°C under
saturated water vapour pressure for 20 hrs [20]. In an autoclave, a-TCP
is reacted with water, the a-TCP dissolves into water, the supersaturation
with respect to HA is achieved and HA is formed [21]. Synthesized HHA
granules were sieved and granules 0.5–0.6 mm in diameter were used
for experiments. Spherical CHA granules were prepared by sintering at
900°C for 3 hrs from the same chemical purity grade HA powders with
stoichiometric composition. The porosity of HHA and CHA granules was
designed to be 70%.
Serum protein adsorption to ceramic granules
To analyse the optimum conditions of adsorption and elution of serum
proteins, standard procedures for HA column chromatography were
used [22–24]. Four hundred mg of HHA or CHA granules was inserted
into an Econo-Column (Bio-Rad, Hercules, CA, USA), equilibrated with
0.05 M sodium phosphate buffer (pH. 6.8), and 12 mg of human c-
globulin (Keketsuken, Kumamoto, Japan) or bovine serum albumin
(BSA; MP Biomedicals, Aurora, OH, USA) dissolved in 2 ml of 0.05 M
sodium phosphate buffer was applied. Each column was washed with
3 ml of 0.05 M sodium phosphate buffer three times, and bound mate-
rials were eluted with 2 ml each of 0.05 M sodium phosphate buffer
with stepwise increase in the concentration of NaCl (0.2, 0.4, 0.6, 0.8
and 1.0 M). The other columns, each of which contained HHA or CHA
granules, were eluted with 2 ml each of 0.5 M sodium phosphate buffer
(pH. 6.8) followed by 0.5 M sodium phosphate buffer with stepwise
increase in the concentration of NaCl (0.2, 0.4, 0.6 and 0.8 M).
The optimum time for adsorption of serum proteins was analysed as
follows. One hundred mg of HHA or CHA granules was inserted into a
2 ml microcentrifuge tube, equilibrated with 0.05 M sodium phosphate
buffer at 4°C overnight, and 50 ll of normal human serum (Infectrol
E-00; Kyowa Medex Co., Tokyo, Japan) diluted with 450 ll of 0.05 M
sodium phosphate buffer was applied and adsorbed with gentle shaking
at 4°C for 1, 4, 12, 24 and 48 hrs. After each period of adsorption, cera-
mic granules were washed with 1 ml of 0.05 M sodium phosphate buffer
three times for 5 min. each with gentle shaking at 4°C, then eluted with
0.5 ml of 0.5 M sodium phosphate buffer for 1 hr with gentle shaking at
4°C. Protein quantification was performed by colorimetry using a Pierce
BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA).
Eluates for chemotactic assay and quantitative proteomic analysis were
prepared as follows. Six hundred mg of each type of ceramic granule was
divided into three samples of 200 mg of granules, and each of these sam-
ples was inserted into a plastic tube (Falcon 2063; BD Falcon Labware,
Franklin Lakes, NJ, USA) and equilibrated with 0.05 M sodium phosphate
buffer at 4°C overnight. The next day, the buffer was discarded, and 200 ll
of normal human serum (Infectrol E-00; Kyowa Medex Co.) diluted with
200 ll of 0.05 M sodium phosphate buffer was applied to the ceramic
granules in each plastic tube and adsorbed at 4°C for 24 hrs with gentle
shaking. The supernatant was removed and ceramic granules were washed
with 3 ml of 0.05 M sodium phosphate buffer three times for 5 min. each
with gentle shaking at 4°C, then eluted with 0.5 ml of 0.5 M sodium phos-
phate buffer for 10 min. with gentle shaking at 4°C. Part of each eluate was
used for protein quantification and the remainder was combined for each
kind of ceramic and dialyzed in PBS using Slide-A-Lyzer Dialysis Cassettes
(Thermo Scientific) following the manufacturer’s instructions. Part of the
dialyzed sample was used for protein quantification and the remainder was
used for chemotactic assay and quantitative proteomic analysis. For che-
motactic assay, each eluate was adjusted to a protein concentration of
240 lg/ml. Quantitative proteomic analysis was performed with an iTRAQ
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system, which was consigned to Filgen Inc., Nagoya, Japan. Normal mouse
serum (Nippon SLC, Fukuoka, Japan) was adsorbed, eluted and dialyzed as
described above, and used for SDS-PAGE analysis.
Chemotactic assay
Mouse bone marrow macrophages prepared from femurs and tibiae of 5-
week-old female ddY mice were expanded in vitro in a-minimum essen-
tial medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with
10% foetal bovine serum and 30 ng/ml macrophage colony-stimulating
factor (M-CSF; Sigma-Aldrich) as described previously [12]. 1 9 105
macrophages suspended in 400 ll of serum-free a-minimum essential
medium supplemented with 30 ng/ml M-CSF were added to a chamber
(Chemotaxicell 5 lm pore size; Kurabo, Osaka, Japan). The chamber was
immediately inserted into a 24-type well with 800 ll of the serum-free
culture medium supplemented with 30 ng/ml M-CSF and an eluate from
HHA or CHA granules adsorbed to normal human serum. The volume of
an eluate added to the culture medium was adjusted to 80 ll. Chemotac-
tic assay supplemented with M-CSF and DBP or DBP-maf in the bottom
well was also performed in the same manner. As a control, 80 ll of PBS
was added to the culture medium. After 8 hrs, chambers were fixed with
methanol, stained with Mayer’s haematoxylin and macrophages that
migrated from the 5-lm-pore-sized membrane were quantified using an
industrial epi-illumination microscope (ECLIPSE LV100D; Nikon, Tokyo,
Japan) equipped with a digital camera (DS-Ri1-U2; Nikon).
Data were evaluated with the t-test using the results of three inde-
pendent experiments and a P < 0.05 was considered significant.
Preparation of vitamin D-binding protein (DBP)-
macrophage activating factor (DBP-maf)
Vitamin D-binding protein-maf was prepared by deglycosylation of DBP,
also known as Gc-globulin (Mixed Type, Human Plasma; Merck, Darms-
tadt, Germany) as described previously [25]. Prior to deglycosylation,
b-D-galactosidase-Sepharose beads were prepared as follows. Cyano-
gen bromide-activated Sepharose 4B (GE Healthcare Life Sciences, Upp-
sala, Sweden) was washed with 1 mM HCl, followed by washing with
DDW and equilibration with coupling buffer (0.1 M NaHCO3, 0.5 M
NaCl, pH 8.3). Thousand units of b-D-galactosidase (Wako Pure Chemi-
cal Ind., Osaka, Japan) were then added to 0.5 g of equilibrated Sepha-
rose 4B for 2 hrs at room temperature, and the following methods to
prepare b-D-galactosidase-Sepharose beads were as described previ-
ously [26]. The enzymatic activity of b-D-galactosidase-Sepharose
beads was determined using 2-nitrophenyl-b-D-galactopyranoside
(Sigma-Aldrich). DBP was deglycosylated with 0.02 U of b-D-galactosi-
dase-Sepharose and 0.01 U of neuraminidase-agarose (Sigma-Aldrich)
beads under conditions of 0.05 mg/ml in PBS (pH 6.0) with 10 mM
MgCl2 at room temperature for 4 hrs. After removing the beads by cen-
trifugation, supernatant was used for biological assays as DBP-maf
solution.
Quantification of adsorbed DBP
D-binding protein was adsorbed to HHA and CHA granules following the
method to prepare human serum eluates for chemotactic assay and
quantitative proteomic analysis as described above. Instead of 200 ll of
normal human serum diluted with 200 ll of 0.05 M sodium phosphate
buffer, 0.5 mg of DBP diluted in 400 ll of 0.05 M sodium phosphate
buffer was applied to the ceramic granules in each plastic tube and
adsorbed at 4°C for 24 hrs with gentle shaking, then eluted with 0.5 ml
of 0.5 M sodium phosphate buffer for 10 min. with gentle shaking at
4°C. Protein quantification was performed with a Quantikine Human
Vitamin D-Binding Protein Immunoassay kit (R&D Systems Inc., Minne-
apolis, MN, USA).
For in vivo experiments, 10 female 8-week-old Wistar rats were anaes-
thetized, a dead-end bone defect 2 mm in diameter and 3 mm in depth
was created in the medial cortex of the right femur just proximal to the
epiphyseal growth plate using a Kirschner wire. The defect was irrigated
with saline, 15 mg of HTCP or CTCP granules was implanted into the
defect. Five animals were used for each ceramic. Two days after the
implantation, animals were killed and ceramic granules were recovered.
After the washing with 0.05 M sodium phosphate buffer for 6 hrs, pro-
teins were eluted with 0.5 M sodium phosphate buffer for 12 hrs with
gentle shaking. The buffer and ceramic granules were then grinded in an
agate mortar with a pestle and the supernatant was recovered after centri-
fugation. Protein quantification was performed by colorimetry as described
above, and DBP was quantified using a Rat gc-globulin ELISA test kit (Life
Diagnostics Inc., West Chester, PA, USA). Animal rearing and experiments
were performed at the Biomedical Research Center, Center for Frontier
Life Sciences, Nagasaki University, following the Guidelines for Animal
Experimentation of Nagasaki University (Approval No. 0703010564).
In vitro osteoclastogenesis
Mouse bone marrow macrophages prepared from the femora and tibiae
of 5-week-old female ddY mice were expanded in vitro in a-minimum
essential medium supplemented with 10% foetal bovine serum and
30 ng/ml M-CSF (Sigma-Aldrich). The macrophages (1 9 104 cells/
cm2) were mixed with NIH3T3 cells (1 9 104 cells/cm2) expressing
human RANKL cDNA [27] and mouse M-CSF, and seeded in 48-well
plates with a-minimum essential medium supplemented with 10% foetal
bovine serum and 0.01, 0.1 or 1 lg/ml DBP, DBP-maf or PBS. These
culture media were changed every other day up to day 6 of the culture
period. At day 7, these cultures were fixed with 4% paraformaldehyde
in 0.1 M sodium phosphate buffer (pH 7.2) for 10 min. and tartrate-
resistant acid phosphatase (TRAP) activity was stained using fast red
RC salt (Sigma-Aldrich) as a coupler and naphthol AS-MX phosphate
(Sigma-Aldrich) as a diazonium salt as described previously [27]. Multi-
nucleated cells with more than three nuclei were counted. Four 48-wells
for each concentration of DBP or DBP-maf were analysed and data were
evaluated with the t-test. P < 0.05 was considered significant.
Results
Prepared ceramic granules
Rod-shaped particles of spherical HHA granules and globular-shaped
particles of spherical CHA granules were confirmed by a scanning
electron microscope (SU8000; Hitachi, Ltd., Tokyo, Japan; Fig. 1).
Synthesized HHA and CHA granules were analysed by powder X-ray
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diffractometry with graphite-monochromatized CuKa radiation,
operating at 40 kV and 40 mA (XRD; RINT-2200VL; Rigaku, Tokyo,
Japan). We confirmed that the main phases of HHA and CHA were HA
(Fig. 2).
Serum protein adsorption
Protein concentrations in eluates with stepwise increase in the con-
centration of NaCl in 0.05 or 0.5 M sodium phosphate buffer were
analysed. When using a 0.05 M sodium phosphate buffer, c-globulin
and BSA were largely eluted with more than 0.4 M NaCl for eluates
from both HHA and CHA granules (Fig. 3A). When using a 0.5 M
sodium phosphate buffer, c-globulin and BSA were effectively eluted
without NaCl, but the addition of 0.2 M NaCl was helpful (Fig. 3B). To
evaluate the time-dependent efficacy of protein adsorption to ceramic
granules, normal human serum was adsorbed to HHA and CHA gran-
ules for 1, 4, 12, 24 and 48 hrs. The amount of adsorbed serum pro-
teins reached a maximum at 24 hrs. The amount of human serum
proteins adsorbed to HHA was about 20% greater than that adsorbed
to CHA (Fig. 3C).
Serum protein profiles of eluates from HHA and CHA were anal-
ysed by SDS-PAGE. Compared with original mouse serum, serum




Fig. 1 Scanning electron micrographs of
the overview (A and D) and the micro-
structure (B, C, E and F) of HHA (A–C)
and CHA (D–F) granules.
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Fig. 2 X-ray diffractometry (XRD) of implants used in this study. From
XRD patterns, the main phases of HHA and CHA were assigned to HA.
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eluates, but immunoglobulin (indicated by an arrowhead) remained.
Protein profiles in eluates from HHA and CHA were similar
(Fig. 3D).
Quantitative proteomic analysis
Serum proteins adsorbed to HHA were quantitatively compared with
those adsorbed to CHA using quantitative proteomic analysis. A sum-
mary of the proteins that were adsorbed to HHA more abundantly
than CHA was shown in Table 1. Among them, the serum protein that
preferentially adsorbed to HHA at the highest ratio was DBP. About
19-fold DBP was adsorbed to HHA compared with CHA, and the dif-
ference was statistically significant. In addition, about 2.7-fold com-
plement C3 and 2.1-fold complement C4B adsorbed to HHA
compared with CHA. These differences were statistically significant.
Except for these proteins, there were few proteins that had a strong
relationship with osteoclast activity, bone metabolism or cell
adhesion. The affinity for DBP was further quantified by ELISA, and
about fourfold more human DBP was adsorbed to HHA than CHA
(Fig. 4A). For the reference, the binding capacity of human serum
proteins was also analysed. HHA adsorbed about 1.2-fold more
serum proteins compared with CHA (Fig. 4B), and the result was con-
sistent with that in Fig. 3C. The amount of DBP adsorbed to HHA
implanted with the rat femur for 2 days was significantly larger than
that in CHA implanted with the rat femur for 2 days (Fig. 4C), but
total amount of protein adsorbed to HHA and CHA were not signifi-
cantly different (Fig. 4D).
Chemotactic activity
The migration of macrophages inserted into the chambers through
micropores of 5 lm in diameter was analysed at 8 hrs. With an eluate
from HHA in the bottom well, the number of macrophages that





























































Fig. 3 Evaluations of the adsorption of serum proteins to HHA and CHA granules. (A and B) Effects of concentrations of phosphate and NaCl. The
amount of c-globulin and BSA eluted by 0.05 M sodium phosphate buffer (A) and that eluted by 0.5 M sodium phosphate buffer (B) from 400 mg
of HHA and CHA granules are shown. (C) Time-dependent variations of the amount of human serum proteins adsorbed to 100 mg of HHA and CHA
granules. (D) Protein profiles from SDS-PAGE analysis of eluates of HHA and CHA adsorbed to mouse serum.
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an eluate of CHA in the bottom well. A dose-dependent increase in the
number of migrated macrophages was detected in the experiments
with eluates from HHA (Fig. 5A and B). In these experiments, the low-
est protein concentration in the bottom well was 3 lg/ml and, at this
concentration, the numbers of migrated macrophages with eluates of
HHA and of CHA were not significantly different, although both of
them were significantly larger than that of the control, in which PBS
was added to the bottom well (Fig. 5B).
The chemotactic activities of DBP and DBP-maf were also analy-
sed. In the presence of 0.0001, 0.01 and 0.1 lg/ml human DBP or
DBP-maf in the bottom well, chemotaxis of macrophages to the
bottom was weak and no significant difference was seen between
DBP and DBP-maf (Fig. 6).
Osteoclastogenesis
The biological activities of DBP and DBP-maf on osteoclastogenesis
were analysed using an in vitro coculture system. Without supple-
mentation of DBP or DBP-maf, TRAP-positive cells were abundantly
detected. However, the number of multinucleated osteoclasts was
limited compared with that of mononuclear pre-osteoclasts. Supple-
Table 1 Quantitative proteomic analysis of serum proteins adsorbed to HHA and CHA




IPI00555812.4 GC Isoform 1 of Vitamin D-binding protein 64.35 19.307 0.014
IPI00940791.1 TTR 20 kD protein 87.03 9.118 0.000
IPI00953689.1 AHSG Alpha-2-HS-glycoprotein 100.00 8.219 0.000
IPI00299435.3 APOF apolipoprotein F precursor 85.28 6.641 0.004
IPI00019581.1 F12 Coagulation factor XII 90.57 6.106 0.000
IPI00553177.1 SERPINA1 Isoform 1 of Alpha-1-antitrypsin 82.06 5.556 0.000
IPI00853525.1 APOA1 Apolipoprotein A1 91.84 4.851 0.008
IPI00942787.1 HP 42 kD protein 95.55 4.409 0.000
IPI00783987.2 C3 Complement C3 (Fragment) 91.94 2.743 0.000
IPI00418163.3 C4B complement component 4B pre-pro-protein 92.95 2.148 0.006
IPI00017601.1 CP Ceruloplasmin 73.99 1.460 0.269
IPI00021885.1 FGA Isoform 1 of Fibrinogen alpha chain 87.07 1.311 0.318
IPI00218624.1 SON Isoform I of Protein SON 90.88 1.268 0.141
IPI00749267.2 - Conserved hypothetical protein 59.14 1.265 0.080
IPI00879931.1 SERPING1 cDNA FLJ58826, highly similar to Plasma
protease C1 inhibitor
97.24 1.229
IPI00921610.1 DSPP Dentin sialophosphoprotein (Fragment) 99.72 1.154 0.060
IPI00872497.4 EI24 Etoposide-induced protein 2.4 homologue 83.29 1.152 0.535
IPI00893362.1 RYR3 Putative uncharacterized protein RYR3 88.70 1.087 0.335
IPI00759691.3 BRDT Isoform 2 of Bromodomain testis-specific protein 80.00 1.073 0.422
IPI00385250.1 PRSS3 Protease serine 4 isoform B 100.00 1.043 0.776
IPI00011769.1 NR5A2 Isoform 2 of Nuclear receptor subfamily 5 group A member 2 80.59 1.024 0.739
IPI00550906.6 CSTF2T Cleavage stimulation factor 64 kD subunit, tau variant 96.10 1.004
IPI00945846.1 PRSS1 28 kD protein 96.9 0.9916 0.7426
P < 0.05 was considered to be statistically significant.
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mentation of DBP to the culture medium revealed much less effect on
osteoclastogenesis than DBP-maf. When supplemented with 0.1 or
1 lg/ml DBP-maf, the number of multinucleated osteoclasts obvi-
ously increased (Fig. 7).
Discussion
Previously, we developed HHA using applied hydrothermal methods
[10]. When implanted in the bone, HHA expressed potent osteogenic
and osteoclast homing activities compared with CHA [11, 12]. The
different biological behaviour of HHA compared with that of CHA in
bone promoted us to analyse the mechanism behind the difference.
HA has been applied to column chromatography in biochemical fields
and its affinity for proteins might affect the biological behaviour of HA
in bone. HA column is widely used to isolate various kinds of proteins
because of its wide range of affinity for them [22–24]. Porous HA
used as a bone substitute absorbs blood or extracellular fluid in the
implanted region, and we analysed human serum proteins adsorbed
to HHA and CHA considering an application of these ceramics to
human patients. Quantitative proteomic analysis revealed notably
different profiles of serum proteins adsorbed to HHA and CHA, and a
larger amount of DBP was adsorbed to HHA than to CHA at the high-
est ratio (Table 1). DBP is one of the serum proteins that are relatively
abundant. Vitamin D-binding protein-maf has a variety of biological
functions, and one of its main functions is to transport vitamin D and
its metabolites [28–30]. Vitamin D is known to be indispensable to
maintain normal bone metabolism, and DBP may have important
physiological functions for bone metabolism. The binding of DBP with
complement C5a was reported to enhance the chemotactic activity of
C5a for neutrophils and macrophages, whereas DBP itself did not
have this function [31, 32]. Although DBP-deficient mice did not have
any apparent abnormality, in vivo administration of DBP-maf in osteo-
petrotic mice increased the population and activity of macrophages,
and DBP-maf was suggested to contribute to the growth and stimula-
tion of macrophages [33–36]. Stimulation of osteoclast activity by
DBP-maf was also reported using an in vitro culture system [37].
However, this in vitro study was performed with isolated rat osteo-
clasts and the contribution of DBP and DBP-maf to osteoclastogene-
sis remained unclear.
In this study, the biological function of DBP, which was preferen-
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Fig. 4 Quantification of DBP and serum proteins adsorbed to HHA and CHA. (A) DBP was adsorbed to HHA and CHA, and DBP in each eluate was
quantified by ELISA. (B) Normal human serum was adsorbed to HHA and CHA, and serum protein in each eluate was quantified by colorimetry. (C
and D) DBP (C) and total proteins (D) adsorbed to HHA and CHA implanted with the rat femur was quantified by ELISA and colorimetry, respec-
tively. Twenty milligram of wet ceramic granules included ~11 mg of dry ceramic granules. Data were evaluated using the t-test with the results
from three individual experiments. *P < 0.05, **P < 0.01.
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chemotaxis of macrophages and osteoclastogenesis was analysed. In
our system, the macrophage chemotactic activity of DBP and DBP-
maf was very weak. Interestingly, an eluate from HHA adsorbed to
normal human serum expressed significantly higher macrophage
chemotactic activity than that from CHA (Fig. 5). The contribution of
DBP to higher macrophage chemotactic activity of the eluate of HHA
was not completely ruled out, but these findings strongly suggested
that other factors included in the eluate of HHA caused induction of
its higher chemotactic activity.
We precisely analysed the biological function of DBP and DBP-
maf in osteoclastogenesis using an osteoclast coculture system
[27]. Supplementation of DBP to the culture medium revealed little
effect on osteoclastogenesis (Fig. 7). In this coculture system, we
used culture medium supplemented with 10% foetal bovine serum.
According to previous studies, the mean serum concentration of
DBP is about 200–500 lg/ml [38, 39], and about 20–50 lg/ml
DBP derived from foetal bovine serum was expected to be
included in the culture medium. The stability and reactivity of DBP
included in foetal bovine serum to mouse macrophages were
unclear, but it was likely that supplementation of 0.01, 0.1 and
1 lg/ml human DBP had little effect in this culture system con-
taining DBP derived from foetal bovine serum. In contrast, our
results clearly showed that DBP-maf stimulated osteoclastogenesis
(Fig. 7). Deglycosylation of DBP requires galactosidase and
neuraminidase activities, and they were high in neutrophils and
lymphocytes. Although the significance of preferential adsorption
HHA 
CHA 























Fig. 5 Chemotactic activity of eluates from HHA and CHA adsorbed to human serum. (A) Microscopic views of chemotactic assay using mouse bone
marrow macrophages that migrated through the chamber. 0, 3, 6, 12 and 24 (lg/ml) represent final concentrations of serum proteins in eluates
from HHA and CHA added to the bottom well. (B) Quantification of the number of migrated cells in chemotactic assay. *P < 0.05, ***P < 0.001.
Fig. 6 Chemotactic activity of DBP and DBP-maf. Quantification and
comparison of the number of migrated cells with DBP in the bottom
well and that with DBP-maf in the bottom well. 0, 0.0001, 0.001, 0.01,
0.1 and 1 (lg/ml) represent final concentrations of DBP and DBP-maf
added to the bottom well. *P < 0.05, **P < 0.01.
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of DBP to HHA was not completely clarified in this study, there
was a possibility that certain cells in the implanted region like neu-
trophils and lymphocytes expressed galactosidase and/or neur-
aminidase and synthesized a larger amount of DBP-maf in the
region implanted with HHA than that implanted with CHA, and con-
tributed to the potent osteoclast homing activity of HHA through
the stimulation of osteoclastogenesis.
Among the list of components subjected to quantitative proteomic
analysis, complements C3 and C4B adsorbed to HHA more than twice
as much as CHA. These complements act as opsonins that bind with
receptors on neutrophils and macrophages and promote their phago-
cytosis of coated cells [40]. Interestingly, C3 was suggested to medi-
ate the recruitment of osteoclasts to bone surface [41]. In addition,
C3 itself was suggested to promote osteoclastogenesis [42–44]. Con-
sidering the results of these studies, C3 and C4B, especially C3, were
thought to be candidates for proteins associated with the potent
osteoclast homing activity of HHA.
The reason why the protein affinity is different between HHA and
CHA remained unclear. It has been suggested that the HA crystal
exposes different kinds of adsorption sites depending on the crystal
face. Kawasaki et al. suggested that the a-face (the side surface of the
hexagonal HA crystal) exposed positively charged sites [45]. Rod-
shaped particles in HHA were thought to dominantly expose the a-face
compared with the c-face (the top and the bottom surfaces of the hex-
agonal HA crystal). On the other hand, particles in CHA were thought to
expose the crystal face randomly. The difference in the exposed crystal
faces between HHA and CHA was thought to affect the adsorption
properties. Moreover, different pore structures between HHA and CHA
may also have affected the affinity for proteins. In conclusion, serum
proteins preferentially adsorbed to HHA were analysed and their rela-
tionship with the potent osteoclast homing activity of HHA in the
implanted region was discussed. Quantitative proteomic analysis of el-
uates from HHA and CHA absorbed to normal human serum revealed
preferential adsorption of DBP to HHA at the highest ratio compared
with CHA. In addition, larger amounts of complements C3 and C4B
were also detected in an eluate from HHA than from CHA. In vitro che-
motactic analysis using chambers revealed that an eluate from HHA
had significantly higher chemotactic activity than that from CHA, but
the chemotactic activity of DBP and DBP-maf to macrophages was very
weak. These results suggested that the higher chemotactic activity of
A
B C D
Fig. 7 Influence of DBP and DBP-maf on osteoclastogenesis. Mouse bone marrow macrophages were cultured with RANKL-expressing fibroblasts.
At day 7, cultures were fixed and TRAP activity was coloured red. 0, 0.01, 0.1 and 1 (lg/ml) represent final concentrations of DBP or DBP-maf in
the culture medium. (A) Microscopic views of osteoclasts. (B and C) Quantification of osteoclasts/well treated with DBP (B) or DBP-maf (C).
(D) Comparison of the number of osteoclasts treated with DBP and that treated with DBP-maf. *P < 0.05, **P < 0.01, ***P < 0.001.
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an eluate from HHA than from CHA was induced not by DBP, but by
other factors. Vitamin D-binding protein-maf stimulated osteoclasto-
genesis, and much of the DBP adsorbed to HHA might be deglycosylat-
ed and formed DBP-maf by certain cells with galactosidase and/or
neuraminidase activity, like neutrophils and lymphocytes in the
implanted region, which may be associated with the potent in vivo
osteoclast homing activity of HHA in concert with the stimulation of os-
teoclastogenesis by C3 and opsonization promoted by C3 and C4B.
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